Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.63 [0.5-0.81],0.000331238032089209,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,31,1.13 [1.05-1.23],0.00163768157013564,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.69 [0.53-0.88],0.00354151315732414,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,1.3 [1.09-1.57],0.00443541174809876,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LAYN,Layilin,Inverse variance weighted,20,0.76 [0.63-0.93],0.00586514377754181,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.62 [0.42-0.9],0.0123081508122614,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.22 [1.04-1.44],0.0164862764100086,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CXCL8,Interleukin-8,Inverse variance weighted,6,1.79 [1.11-2.88],0.0173897304096569,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,0.87 [0.78-0.98],0.0183622405370869,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,APOA2,Apolipoprotein A-II,Wald ratio,1,0.33 [0.13-0.85],0.0215500862680927,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,0.8 [0.66-0.97],0.023438658200643,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.62 [1.06-2.47],0.024375905737634,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.14 [1.02-1.27],0.0257550105238566,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,DCTPP1,dCTP pyrophosphatase 1,Wald ratio,1,0.19 [0.04-0.83],0.0270232247896491,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LMNB2,Lamin-B2,Wald ratio,1,0.2 [0.04-0.88],0.0328262109911116,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PALM2,Paralemmin-2,Inverse variance weighted,8,1.31 [1.02-1.67],0.0355918972863714,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.14 [1.01-1.3],0.0374031826101071,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.35 [0.13-0.94],0.037420134276182,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.51 [1.01-2.25],0.0429707251516327,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.84 [0.7-1],0.0444212231936072,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.4 [1.01-1.96],0.0459219684484853,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.9 [0.8-1],0.0478162321566753,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.64 [0.41-1],0.0486426065007585,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,0.92 [0.85-1],0.0511447782981278,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,OGN,Mimecan,Inverse variance weighted,30,0.88 [0.78-1],0.0515464048405441,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.49 [0.24-1.01],0.0526487917734797,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PRSS2,Trypsin-2,Inverse variance weighted,3,1.47 [0.99-2.18],0.0545473871606615,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,AGRN,Agrin,Inverse variance weighted,17,0.81 [0.65-1.01],0.0567854052375332,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.33 [0.99-1.79],0.0586782731329669,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,0.84 [0.7-1.01],0.0590497748543722,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,AREG,Amphiregulin,Inverse variance weighted,3,1.45 [0.97-2.16],0.0681526869536781,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1.17 [0.99-1.38],0.070603129157129,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.11 [0.99-1.25],0.0742847112750832,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.85 [0.72-1.02],0.0748326611139387,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,KLK11,Kallikrein-11,Inverse variance weighted,6,1.12 [0.99-1.28],0.0751974232033022,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,1.43 [0.96-2.13],0.075286851919054,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.51 [0.25-1.07],0.0761865978676976,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,0.73 [0.51-1.04],0.0787715090720945,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,0.76 [0.56-1.03],0.0799610799545331,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ANXA10,Annexin A10,Wald ratio,1,2.84 [0.85-9.49],0.0896318962094203,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1.11 [0.98-1.25],0.0901658868375601,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,0.92 [0.83-1.01],0.0926227321514639,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,0.85 [0.7-1.03],0.0936184750336813,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.59 [0.31-1.1],0.0980865444130724,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.57 [0.91-2.72],0.1024898432515,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,1.12 [0.97-1.3],0.110439246238626,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.89 [0.77-1.03],0.111212499624465,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.82 [0.64-1.05],0.113106058735866,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MATN2,Matrilin-2,Inverse variance weighted,18,1.17 [0.96-1.42],0.113442585474187,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,1.15 [0.97-1.35],0.113475174366345,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.86 [0.71-1.04],0.113555277356676,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,0.88 [0.74-1.04],0.121753895540821,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.7 [0.87-3.35],0.12205747774187,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.88 [0.74-1.04],0.122671064820511,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.28 [0.93-1.76],0.122699111893351,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.75 [0.51-1.08],0.124772982491704,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.84 [0.67-1.05],0.12904833702791,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,REN,Renin,Inverse variance weighted,4,1.18 [0.95-1.47],0.129707923789939,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,0.91 [0.8-1.03],0.130272257091693,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1.42 [0.89-2.25],0.143030019912654,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.65 [0.36-1.16],0.143932799103819,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CLEC3B,Tetranectin,Inverse variance weighted,7,0.83 [0.64-1.07],0.148062705198285,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LGMN,Legumain,Inverse variance weighted,12,1.13 [0.96-1.33],0.150818719666808,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.09 [0.97-1.23],0.153483604326522,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,1.85 [0.79-4.35],0.157453406677865,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,0.69 [0.4-1.16],0.160744803826186,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,3,0.72 [0.46-1.15],0.167313707750879,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,1.24 [0.91-1.69],0.170556754741513,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.13 [0.95-1.34],0.172911136743182,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SPON2,Spondin-2,Inverse variance weighted,4,1.26 [0.9-1.77],0.179103129748769,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,F10,Coagulation factor X,Inverse variance weighted,9,0.94 [0.85-1.03],0.182307550670037,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.1 [0.96-1.27],0.182616013384176,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,2.4 [0.64-8.96],0.193242672615385,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,0.86 [0.68-1.08],0.196751187687073,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.87 [0.7-1.07],0.196841831729895,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1.13 [0.94-1.35],0.19764894644368,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,THBD,Thrombomodulin,Inverse variance weighted,5,1.22 [0.9-1.65],0.197737802766091,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD276,CD276 antigen,Inverse variance weighted,20,1.09 [0.95-1.25],0.200272019186962,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.19 [0.91-1.57],0.200382272255431,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,2.54 [0.61-10.62],0.200532215461798,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,0.91 [0.79-1.05],0.201656926483582,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.43 [0.82-2.49],0.202470540136805,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.16 [0.92-1.46],0.202543816211375,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.1 [0.95-1.28],0.203982566518374,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,1.53 [0.79-2.97],0.208731341382448,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.76 [0.5-1.16],0.209434862958021,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.95 [0.87-1.03],0.212404286218266,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.87 [0.69-1.09],0.218725784602974,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.15 [0.92-1.46],0.223366460305744,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.18 [0.9-1.53],0.227850078103585,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.52 [0.18-1.52],0.234885191891194,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CALB1,Calbindin,Inverse variance weighted,2,0.64 [0.31-1.35],0.242483484997981,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,1.1 [0.94-1.29],0.242647335137666,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.26 [0.85-1.88],0.248454057736207,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MMP10,Stromelysin-2,Inverse variance weighted,22,0.89 [0.73-1.09],0.25170490265796,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,0.79 [0.52-1.19],0.255785617903178,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.84 [0.63-1.13],0.258250193966288,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.71 [0.4-1.28],0.26042860399727,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1.34 [0.8-2.25],0.261820159391977,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.81 [0.56-1.17],0.265426338959873,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PENK,Proenkephalin-A,Inverse variance weighted,19,0.91 [0.78-1.07],0.269825448407621,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,1.13 [0.91-1.41],0.271456511455913,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,0.96 [0.88-1.04],0.274922878778821,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CTSS,Cathepsin S,Inverse variance weighted,23,1.07 [0.95-1.21],0.280619396259579,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,COLEC12,Collectin-12,Inverse variance weighted,11,1.14 [0.9-1.44],0.284866270787363,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,0.88 [0.69-1.12],0.288107298592645,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,0.94 [0.83-1.06],0.29385204637825,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LAMB1,Laminin subunit beta-1,Inverse variance weighted,35,1.06 [0.95-1.19],0.295283064644791,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.72 [0.38-1.34],0.295799427161849,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,0.9 [0.75-1.09],0.297414987208447,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.42 [0.08-2.14],0.297786869057364,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.15 [0.88-1.51],0.300578993197341,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PI3,Elafin,Inverse variance weighted,10,1.1 [0.91-1.33],0.302654127730671,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NFASC,Neurofascin,Inverse variance weighted,15,1.08 [0.93-1.26],0.306272155589833,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.9 [0.74-1.1],0.310800603208259,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.69 [0.61-4.69],0.311248132721541,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PTN,Pleiotrophin,Inverse variance weighted,4,1.31 [0.77-2.22],0.316599739898529,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MMP8,Neutrophil collagenase,Inverse variance weighted,17,0.94 [0.83-1.06],0.318229386283656,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.16 [0.87-1.54],0.321893721995925,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL15,Interleukin-15,Wald ratio,1,0.06 [0-16.17],0.321968628737645,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,0.86 [0.64-1.16],0.329644550504667,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LGALS4,Galectin-4,Inverse variance weighted,4,0.83 [0.57-1.21],0.330412278105705,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.06 [0.94-1.19],0.331578542640288,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.71 [0.58-5.11],0.333475025552716,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.96 [0.88-1.04],0.336220541594732,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NECTIN4,Nectin-4,Inverse variance weighted,7,1.09 [0.91-1.31],0.339485058235788,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,EPO,Erythropoietin,Inverse variance weighted,5,1.41 [0.69-2.88],0.33988094039813,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.94 [0.83-1.07],0.343183851201302,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.1 [0.91-1.32],0.343296782614231,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.81 [0.53-1.25],0.343478167223754,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LGALS9,Galectin-9,Inverse variance weighted,26,1.08 [0.93-1.25],0.344072578609075,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,0.92 [0.79-1.09],0.344184442630089,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD160,CD160 antigen,Inverse variance weighted,11,0.93 [0.8-1.08],0.344640131538595,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.87 [0.66-1.16],0.344725703909122,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,0.95 [0.85-1.06],0.350203608342278,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CSTB,Cystatin-B,Inverse variance weighted,28,1.06 [0.94-1.2],0.352044249432898,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.08 [0.91-1.29],0.353289277651158,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.07 [0.93-1.23],0.354511534027482,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MUC13,Mucin-13,Inverse variance weighted,9,0.89 [0.7-1.14],0.357176053092884,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CST3,Cystatin-C,Inverse variance weighted,10,0.92 [0.76-1.1],0.358115621912993,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,C7,Complement component C7,Inverse variance weighted,38,1.04 [0.96-1.11],0.361069827277785,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.86 [0.63-1.18],0.361575592277629,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TFF3,Trefoil factor 3,Inverse variance weighted,5,0.85 [0.61-1.2],0.363873436505703,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.92 [0.77-1.1],0.366008690720851,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.82 [0.54-1.26],0.368059699669615,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PYY,Peptide YY,Inverse variance weighted,6,1.15 [0.85-1.56],0.369481250322432,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.03 [0.97-1.09],0.372161299387342,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.76 [0.41-1.4],0.373608900769475,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,HSPB6,Heat shock protein beta-6,Wald ratio,1,2.01 [0.43-9.42],0.373775245051828,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.81 [0.51-1.29],0.376251321560738,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,0.87 [0.65-1.18],0.378144780958125,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.08 [0.9-1.3],0.380394947762277,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.13 [0.86-1.47],0.386332738390933,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.16 [0.83-1.6],0.387676387112223,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,1.65 [0.52-5.21],0.390659450870532,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.12 [0.86-1.47],0.391598510252446,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.08 [0.91-1.28],0.392971867233217,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ROBO1,Roundabout homolog 1,Inverse variance weighted,10,1.17 [0.81-1.68],0.395445011186785,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ALCAM,CD166 antigen,Inverse variance weighted,6,0.83 [0.54-1.28],0.396179995104271,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.42 [0.63-3.2],0.399560789327825,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.84 [0.57-1.25],0.400302617261623,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FOLR1,Folate receptor alpha,Inverse variance weighted,5,0.82 [0.52-1.3],0.400334691825688,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,0.95 [0.84-1.07],0.405235027701309,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,0.94 [0.81-1.09],0.408097924834086,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,0.89 [0.68-1.17],0.409296707276645,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CFD,Complement factor D,Inverse variance weighted,11,0.92 [0.76-1.12],0.418195910533793,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,0.86 [0.59-1.24],0.41833681853466,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.94 [0.8-1.1],0.419759912731798,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.8 [0.47-1.37],0.420570425192321,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SNCG,Gamma-synuclein,Inverse variance weighted,36,1.04 [0.94-1.15],0.42060586201124,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,0.86 [0.59-1.25],0.421034188720281,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.72 [0.32-1.62],0.424905177098749,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FOLR2,Folate receptor beta,Inverse variance weighted,2,0.82 [0.49-1.35],0.430321662832724,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,AMBP,Protein AMBP,Inverse variance weighted,3,1.18 [0.79-1.76],0.431201702929767,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.7 [0.29-1.71],0.431664555022159,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,1.08 [0.9-1.29],0.431983608232829,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,0.56 [0.13-2.36],0.433521709029694,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.12 [0.84-1.5],0.436049521556024,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.8 [0.46-1.4],0.438505546571801,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.14 [0.82-1.57],0.443127575960343,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.03 [0.95-1.13],0.446674889406675,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,STC2,Stanniocalcin-2,Inverse variance weighted,3,1.3 [0.66-2.54],0.449277249055137,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,1.29 [0.66-2.52],0.451411963543668,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.05 [0.92-1.2],0.45601922397544,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TMSB10,Thymosin beta-10,Wald ratio,1,1.49 [0.52-4.29],0.457908809523025,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.08 [0.88-1.33],0.458160461386318,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,1.16 [0.79-1.7],0.459228408582657,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,0.86 [0.57-1.29],0.46076499501197,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MB,Myoglobin,Wald ratio,1,1.84 [0.36-9.49],0.465015628310004,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1.07 [0.88-1.3],0.469813540656303,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,1.09 [0.87-1.36],0.470732051845985,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.09 [0.87-1.36],0.475925301753616,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.94 [0.79-1.12],0.484776759711195,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.67 [0.22-2.07],0.487141968689824,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,1.76 [0.35-8.83],0.49240152443553,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,0.96 [0.86-1.07],0.493983471185967,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL19,Interleukin-19,Inverse variance weighted,11,0.93 [0.75-1.15],0.495601854826656,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.03 [0.94-1.13],0.496508779255119,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,0.92 [0.72-1.17],0.497460190834513,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SEPTIN8,Septin-8,Inverse variance weighted,2,0.77 [0.36-1.66],0.501384330847605,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1.04 [0.94-1.15],0.504116370296229,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,KLK10,Kallikrein-10,Inverse variance weighted,15,1.06 [0.9-1.24],0.508701423294874,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD83,CD83 antigen,Inverse variance weighted,5,0.9 [0.66-1.23],0.510485181597918,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.9 [0.64-1.25],0.514760706350235,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.94 [0.78-1.13],0.518571730867331,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.83 [0.47-1.47],0.52578765603344,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.03 [0.93-1.15],0.529988017820077,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,19,1.04 [0.93-1.16],0.535360017427167,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.05 [0.9-1.21],0.536584746389802,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,1.33 [0.54-3.29],0.53677730342871,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.1 [0.82-1.47],0.545166660332505,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.03 [0.93-1.14],0.545786625978996,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.96 [0.85-1.09],0.546108917613914,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,4,1.1 [0.81-1.5],0.546118482373682,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.07 [0.85-1.35],0.547290903642015,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.31 [0.55-3.14],0.548076267120699,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.03 [0.94-1.12],0.549952042831466,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SEMA7A,Semaphorin-7A,Inverse variance weighted,5,1.13 [0.75-1.71],0.553389423087953,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,0.96 [0.83-1.11],0.554213500768229,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.06 [0.87-1.31],0.554465118652012,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNC,Tenascin,Inverse variance weighted,12,0.93 [0.74-1.18],0.557157244403914,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.11 [0.78-1.58],0.55715812213151,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.07 [0.85-1.35],0.557948537221184,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.18 [0.67-2.08],0.561616553059669,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MMP7,Matrilysin,Inverse variance weighted,13,1.05 [0.89-1.24],0.563542259849333,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PLIN3,Perilipin-3,Wald ratio,1,0.78 [0.33-1.82],0.563819800833621,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,1.03 [0.94-1.13],0.566642736970547,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,0.83 [0.45-1.56],0.568775698689908,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.11 [0.77-1.62],0.570220175602464,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,0.91 [0.65-1.27],0.571595808622231,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.14 [0.72-1.81],0.572910904986583,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NRP1,Neuropilin-1,Inverse variance weighted,12,0.94 [0.76-1.16],0.573860136169317,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.13 [0.74-1.73],0.575175914704775,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CHGA,Chromogranin-A,Inverse variance weighted,3,0.9 [0.64-1.28],0.575831081838279,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,OSM,Oncostatin-M,Wald ratio,1,1.28 [0.53-3.1],0.577962480109636,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.9 [0.63-1.29],0.578120040889321,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,0.9 [0.61-1.32],0.579392561406897,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1.04 [0.9-1.2],0.581788702026612,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,0.91 [0.64-1.29],0.582381575815214,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,1.06 [0.87-1.28],0.583186685639193,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.06 [0.85-1.33],0.583282286821255,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.07 [0.85-1.34],0.585450264594845,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,0.92 [0.68-1.24],0.586224051315494,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,RETN,Resistin,Inverse variance weighted,9,1.04 [0.9-1.21],0.588007222408359,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.06 [0.85-1.33],0.591935205659531,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.09 [0.79-1.52],0.59423024345081,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.9 [0.62-1.32],0.595119023701994,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,1.04 [0.89-1.21],0.597641450712717,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.07 [0.84-1.35],0.598824526103967,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ANG,Angiogenin,Inverse variance weighted,19,1.04 [0.91-1.18],0.598831061976751,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1.1 [0.78-1.54],0.598899471128376,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,RTBDN,Retbindin,Inverse variance weighted,3,0.91 [0.65-1.28],0.601612723742532,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.95 [0.79-1.14],0.603650442273599,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CDH1,Cadherin-1,Wald ratio,1,1.41 [0.37-5.31],0.613260819867133,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1.03 [0.92-1.14],0.613904213436692,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,0.93 [0.71-1.23],0.615028706602035,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,1.03 [0.91-1.18],0.615533175718473,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.03 [0.91-1.18],0.615558790721814,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ITGA5,Integrin alpha-5,Wald ratio,1,0.77 [0.27-2.16],0.615895531194435,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ELN,Elastin,Inverse variance weighted,2,0.81 [0.36-1.84],0.6161884979365,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.04 [0.88-1.23],0.619326439408212,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,0.91 [0.64-1.31],0.622214187887289,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.95 [0.77-1.17],0.622288686448141,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.02 [0.93-1.12],0.629512010965875,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.92 [0.65-1.3],0.630580164160558,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.08 [0.8-1.46],0.633951635341827,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.79 [0.31-2.05],0.634312673367868,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CDH6,Cadherin-6,Inverse variance weighted,29,0.98 [0.89-1.08],0.638984510891618,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LGALS3,Galectin-3,Inverse variance weighted,25,0.97 [0.86-1.1],0.640459663010468,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,1.17 [0.59-2.31],0.651144423867646,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,0.94 [0.72-1.23],0.651458339925425,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.03 [0.92-1.15],0.654156386816211,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CTSL,Cathepsin L1,Wald ratio,1,0.74 [0.19-2.82],0.656891086097124,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.95 [0.78-1.17],0.658021708533474,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MARCO,Macrophage receptor MARCO,Inverse variance weighted,10,0.96 [0.78-1.17],0.659865848055073,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.04 [0.86-1.26],0.661999809865875,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.96 [0.79-1.17],0.662894069081861,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1.02 [0.92-1.13],0.664089475484685,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,0.98 [0.89-1.08],0.667944169481121,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.93 [0.66-1.31],0.671635054383223,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MMP3,Stromelysin-1,Inverse variance weighted,34,0.97 [0.84-1.12],0.671721443436771,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.98 [0.89-1.08],0.672849176551048,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CDH2,Cadherin-2,Inverse variance weighted,3,0.75 [0.2-2.85],0.677427998072869,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.4 [0.28-6.92],0.678760342092355,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NECTIN2,Nectin-2,Inverse variance weighted,5,1.04 [0.87-1.24],0.681806523405433,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.9 [0.54-1.5],0.684375857378595,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,0.95 [0.72-1.24],0.686114842640456,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,XCL1,Lymphotactin,Inverse variance weighted,31,0.98 [0.89-1.08],0.686570588323585,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD48,CD48 antigen,Inverse variance weighted,18,0.98 [0.89-1.08],0.690051410968563,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,1.05 [0.83-1.31],0.698358932598255,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.02 [0.91-1.16],0.701079101793975,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.02 [0.92-1.14],0.701540392915186,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.32 [0.32-5.48],0.702238418681244,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,3,1.07 [0.75-1.54],0.708108556078349,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1.02 [0.91-1.15],0.708224167721992,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.01 [0.94-1.1],0.709204683441275,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.04 [0.85-1.27],0.710099901438786,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.98 [0.89-1.08],0.710843301286453,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.13 [0.58-2.19],0.715384574326553,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.97 [0.82-1.14],0.717291233738685,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.92 [0.6-1.42],0.72119048426832,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1.01 [0.95-1.08],0.723876649668383,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.97 [0.8-1.17],0.727898656815028,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.04 [0.83-1.29],0.729279994186056,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,1.03 [0.87-1.21],0.733212222419762,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,0.98 [0.87-1.1],0.733706353658908,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SLAMF7,SLAM family member 7,Inverse variance weighted,20,0.98 [0.89-1.09],0.734257859682888,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.88 [0.42-1.85],0.737103305329378,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.09 [0.65-1.84],0.738151010444871,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.12 [0.57-2.21],0.740350775625009,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.06 [0.74-1.51],0.740529986323188,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.02 [0.89-1.17],0.743723114417133,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1.03 [0.88-1.2],0.74540652916302,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,0.95 [0.68-1.31],0.745844038744926,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PRELP,Prolargin,Inverse variance weighted,9,1.03 [0.86-1.24],0.747211418515157,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.94 [0.64-1.38],0.749304094116107,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.09 [0.63-1.88],0.750176906697235,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PRSS8,Prostasin,Inverse variance weighted,5,1.09 [0.64-1.85],0.750185988680135,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PGF,Placenta growth factor,Inverse variance weighted,2,0.77 [0.15-3.87],0.751473592108279,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.97 [0.77-1.21],0.754286890776697,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,0.97 [0.82-1.16],0.759530012019894,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,0.98 [0.87-1.11],0.761563027034247,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,OCLN,Occludin,Inverse variance weighted,2,1.14 [0.48-2.75],0.762438367149479,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,1.02 [0.9-1.15],0.763957997954787,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.03 [0.85-1.25],0.76490979859755,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,RSPO1,R-spondin-1,Inverse variance weighted,5,0.96 [0.73-1.26],0.765962037570622,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.03 [0.84-1.27],0.768348876094148,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,0.94 [0.62-1.43],0.770089969117922,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,0.9 [0.43-1.87],0.770397097169715,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,0.76 [0.11-5.3],0.78110679314026,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.08 [0.63-1.82],0.787328092141012,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1.01 [0.92-1.11],0.789196083950171,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.98 [0.84-1.15],0.789693717475699,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,DSC2,Desmocollin-2,Inverse variance weighted,9,1.03 [0.81-1.32],0.790738816343288,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,0.93 [0.56-1.56],0.791204643985349,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,0.99 [0.9-1.08],0.795517479864776,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PGA4,Pepsin A-4,Inverse variance weighted,2,0.83 [0.2-3.52],0.798269991840831,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MDK,Midkine,Inverse variance weighted,4,0.95 [0.63-1.42],0.798421062996027,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.1 [0.52-2.35],0.799601190809464,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.11 [0.51-2.42],0.801812728382027,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LGALS1,Galectin-1,Inverse variance weighted,6,1.02 [0.85-1.23],0.804937091048877,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD27,CD27 antigen,Inverse variance weighted,9,1.02 [0.84-1.24],0.806291474720603,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,KLK4,Kallikrein-4,Inverse variance weighted,17,0.98 [0.84-1.14],0.806339360970331,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.06 [0.66-1.69],0.810709936437197,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.03 [0.78-1.37],0.810765232153157,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SPP1,Osteopontin,Inverse variance weighted,8,1.05 [0.69-1.6],0.814613861327381,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.93 [0.52-1.67],0.816430794269943,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,0.98 [0.81-1.18],0.816617213670499,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.02 [0.86-1.2],0.823510155663237,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PSAP,Prosaposin,Inverse variance weighted,5,0.97 [0.74-1.27],0.823592663442873,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SDC1,Syndecan-1,Inverse variance weighted,2,0.95 [0.61-1.48],0.82673296237536,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MFGE8,Lactadherin,Inverse variance weighted,11,0.98 [0.82-1.17],0.828609998033752,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,0.96 [0.68-1.36],0.828946754287023,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.95 [0.62-1.47],0.82995793524267,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,GRN,Progranulin,Inverse variance weighted,7,0.97 [0.72-1.3],0.833908904495424,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,0.99 [0.91-1.07],0.834053732538955,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.95 [0.59-1.53],0.835848673309447,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.05 [0.66-1.66],0.835929155208858,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.96 [0.67-1.38],0.836496007155054,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.01 [0.94-1.08],0.837261838063222,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.03 [0.8-1.32],0.838963305864888,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CALCA,Calcitonin,Inverse variance weighted,5,1.06 [0.62-1.81],0.840737883967309,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.97 [0.69-1.35],0.84232717528011,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,RBP2,Retinol-binding protein 2,Wald ratio,1,1.11 [0.4-3.03],0.843819204033496,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,12,1.03 [0.79-1.34],0.844534176938736,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.98 [0.8-1.2],0.847257221406875,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.02 [0.85-1.21],0.847599426777753,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,3,0.95 [0.54-1.66],0.849785607380579,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.18 [0.22-6.4],0.850511186083953,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FBLN2,Fibulin-2,Inverse variance weighted,11,0.98 [0.82-1.18],0.854178694799743,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FAM3B,Protein FAM3B,Inverse variance weighted,18,0.99 [0.89-1.1],0.857599532012155,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.03 [0.74-1.44],0.863037723095781,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,1.19 [0.16-8.87],0.863469252132644,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD46,Membrane cofactor protein,Wald ratio,1,0.94 [0.47-1.88],0.86454133815006,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,RNASE6,Ribonuclease K6,Inverse variance weighted,15,0.99 [0.86-1.13],0.866266641415954,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,EDN1,Endothelin-1,Inverse variance weighted,3,0.97 [0.7-1.36],0.869855504670202,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,BSG,Basigin,Wald ratio,1,1.04 [0.66-1.62],0.870699836211629,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.98 [0.81-1.19],0.873114705153265,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.06 [0.51-2.22],0.875619038406465,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NPPC,C-type natriuretic peptide,Wald ratio,1,0.89 [0.2-3.89],0.875825820123322,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1.01 [0.9-1.14],0.877392071166433,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCN4,CCN family member 4,Inverse variance weighted,27,0.99 [0.85-1.14],0.878318128300812,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,STC1,Stanniocalcin-1,Inverse variance weighted,2,0.89 [0.2-4.05],0.879715006603555,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SCG2,Secretogranin-2,Wald ratio,1,0.91 [0.25-3.34],0.882050933954004,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,1.01 [0.92-1.1],0.885377223242807,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.01 [0.85-1.21],0.886966338514029,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FABP5,Fatty acid-binding protein 5,Wald ratio,1,0.97 [0.62-1.51],0.887797802478735,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.03 [0.69-1.53],0.890645738272174,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.04 [0.59-1.82],0.892168031705035,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CHGB,Secretogranin-1,Inverse variance weighted,27,0.99 [0.89-1.1],0.892860427966607,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD302,CD302 antigen,Inverse variance weighted,9,1.01 [0.81-1.27],0.8970468856622,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CAPG,Macrophage-capping protein,Inverse variance weighted,33,1.01 [0.89-1.14],0.899293481656594,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,1.03 [0.61-1.75],0.901159704890111,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.01 [0.89-1.13],0.903923327606751,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.92 [0.22-3.89],0.904662967172321,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.98 [0.75-1.29],0.905647940973759,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCN5,CCN family member 5,Inverse variance weighted,8,1.03 [0.62-1.7],0.911377628533073,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,1.01 [0.83-1.24],0.913306942601922,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL17C,Interleukin-17C,Inverse variance weighted,3,0.97 [0.59-1.62],0.916439564606862,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.01 [0.9-1.12],0.918227539335608,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.98 [0.71-1.37],0.918245009318395,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.98 [0.61-1.57],0.921057732023365,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,0.99 [0.85-1.16],0.922353621665001,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,0.99 [0.77-1.26],0.92292636315633,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCN3,CCN family member 3,Inverse variance weighted,19,0.99 [0.8-1.22],0.923316554817742,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,0.96 [0.42-2.22],0.925554289335561,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,1.01 [0.86-1.19],0.926239524613307,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,UMOD,Uromodulin,Inverse variance weighted,29,1 [0.93-1.09],0.926598423894481,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,1 [0.94-1.07],0.929786605413707,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.01 [0.76-1.35],0.930272648356231,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.01 [0.8-1.27],0.934286394647374,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.98 [0.63-1.54],0.938671363805319,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,0.94 [0.21-4.17],0.939068248606595,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1 [0.89-1.14],0.93959276653505,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,0.99 [0.74-1.32],0.942607556229679,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.97 [0.39-2.42],0.949039413452702,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,GUCA2A,Guanylin,Inverse variance weighted,9,1.01 [0.75-1.37],0.949759358282118,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1 [0.87-1.14],0.950108294428653,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.01 [0.7-1.47],0.950906530130583,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,1 [0.87-1.15],0.955007408261813,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,1.01 [0.81-1.24],0.955032933826366,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,NRP2,Neuropilin-2,Inverse variance weighted,11,1.01 [0.82-1.24],0.955663088182924,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.03 [0.37-2.82],0.955941140510617,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,GPR15L,Protein GPR15L,Inverse variance weighted,9,1.01 [0.83-1.22],0.960116131967409,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SPON1,Spondin-1,Inverse variance weighted,21,1 [0.86-1.16],0.961210202806677,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.04 [0.17-6.37],0.96304484739874,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,1 [0.81-1.25],0.965000137139581,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,1.01 [0.58-1.77],0.965831619421326,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CDH3,Cadherin-3,Inverse variance weighted,2,0.99 [0.48-2.02],0.971300989678271,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.01 [0.54-1.88],0.971832359111325,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.01 [0.39-2.66],0.978064934066859,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,RSPO3,R-spondin-3,Inverse variance weighted,6,1.01 [0.56-1.81],0.982182047997766,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1 [0.76-1.31],0.984746844707815,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,1 [0.73-1.36],0.99030403371533,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1 [0.81-1.24],0.992543582718793,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,PRG2,Bone marrow proteoglycan,Wald ratio,1,1 [0.45-2.25],0.992826578826994,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,VWC2,Brorin,Inverse variance weighted,22,1 [0.86-1.17],0.993184206593027,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1 [0.84-1.19],0.996301472732761,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,1 [0.78-1.29],0.998952898780297,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,1 [0.59-1.7],0.999845924628296,cis
Chapter IX Diseases of the circulatory system,I9_CARDARR,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,35.23 [9.92-125.13],3.62775228070124e-08,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.96 [1.33-2.88],0.000607531143014967,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,54,1.13 [1.05-1.21],0.00138669367718723,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FAM3C,Protein FAM3C,Inverse variance weighted,3,2.43 [1.25-4.72],0.00849571922000274,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.5 [1.11-2.04],0.00911206585513702,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,WNT9A,Protein Wnt-9a,Wald ratio,1,0.11 [0.02-0.58],0.00978962637859807,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,1.69 [1.1-2.58],0.0155998160576009,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL15,Interleukin-15,Inverse variance weighted,35,0.79 [0.65-0.96],0.0161317011479996,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,1.71 [1.09-2.66],0.0182975622357971,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.77 [1.08-2.9],0.0228654014721964,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.34 [1.03-1.73],0.0273912263392037,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.28 [0.09-0.9],0.0320340473536562,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,2.28 [1.07-4.89],0.0333108468268848,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,C7,Complement component C7,Inverse variance weighted,26,1.14 [1.01-1.29],0.0370141702105023,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.45 [0.21-0.96],0.0395085151662395,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.29 [1.01-1.66],0.0434132404237721,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.34 [1-1.8],0.0480170170212122,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,KLK4,Kallikrein-4,Inverse variance weighted,5,0.35 [0.12-1],0.0507289783528966,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.69 [0.47-1],0.052756975735089,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MDK,Midkine,Inverse variance weighted,14,1.37 [0.99-1.89],0.0556340797285935,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.21 [1-1.46],0.0558221343476642,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.86 [0.74-1],0.057127541974329,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.33 [0.99-1.79],0.0586782731329669,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD83,CD83 antigen,Inverse variance weighted,14,0.74 [0.54-1.01],0.0593985553335207,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,1.8 [0.97-3.32],0.0604961517837373,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL6,Interleukin-6,Inverse variance weighted,6,0.78 [0.6-1.02],0.0662901544403927,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.23 [0.98-1.53],0.0689649027858204,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1.11 [0.99-1.25],0.0727659452916296,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.34 [0.97-1.85],0.0746076597086176,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,OGN,Mimecan,Inverse variance weighted,37,0.89 [0.79-1.01],0.0774793986204383,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,2.3 [0.91-5.86],0.0800170704035563,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,1.15 [0.98-1.36],0.0801741001393207,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.74 [0.53-1.04],0.0813137457178257,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,3.97 [0.84-18.75],0.0817446466006163,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.59 [0.33-1.07],0.0821074323261446,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.83 [0.92-3.63],0.0856434468436238,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,AREG,Amphiregulin,Inverse variance weighted,5,1.62 [0.93-2.83],0.0867933097178344,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,OCLN,Occludin,Inverse variance weighted,2,2.13 [0.9-5.07],0.087098730491495,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.65 [0.92-2.95],0.0898322097990308,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.57 [0.3-1.09],0.089969536878487,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.17 [0.97-1.4],0.0918007757618724,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LAYN,Layilin,Inverse variance weighted,3,2.05 [0.87-4.8],0.0998557316771844,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.33 [0.95-1.86],0.0998868729589791,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,0.9 [0.79-1.02],0.102009676640264,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,1.21 [0.96-1.51],0.102036387158998,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.54 [0.91-2.61],0.104607256092691,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.2 [0.96-1.51],0.105390942495395,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,AMBP,Protein AMBP,Inverse variance weighted,5,1.35 [0.94-1.95],0.107742557210688,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NRP2,Neuropilin-2,Inverse variance weighted,14,1.32 [0.94-1.86],0.10777908853792,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PALM2,Paralemmin-2,Inverse variance weighted,9,1.25 [0.95-1.66],0.109194827827718,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.8 [0.62-1.05],0.109632441589508,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.96 [0.86-4.51],0.111530591066098,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CXCL8,Interleukin-8,Inverse variance weighted,8,1.31 [0.94-1.83],0.114202492277033,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,1.11 [0.98-1.25],0.11495896369242,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.79 [0.59-1.07],0.12780238715396,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PRSS2,Trypsin-2,Inverse variance weighted,17,0.82 [0.64-1.06],0.129393360244017,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.59 [0.87-2.89],0.129409768009777,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,0.8 [0.59-1.07],0.129558408579825,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CAPG,Macrophage-capping protein,Wald ratio,1,0.41 [0.13-1.3],0.129944892724186,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.89 [0.77-1.04],0.134590568449705,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,0.71 [0.45-1.11],0.134709786257833,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,F10,Coagulation factor X,Inverse variance weighted,11,1.22 [0.94-1.59],0.135338734539885,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,COLEC12,Collectin-12,Inverse variance weighted,3,2.56 [0.74-8.85],0.138242764893388,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MMP10,Stromelysin-2,Wald ratio,1,3.24 [0.68-15.33],0.138829385308165,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CST3,Cystatin-C,Inverse variance weighted,3,1.87 [0.81-4.31],0.141043269540002,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MATN2,Matrilin-2,Inverse variance weighted,28,1.1 [0.97-1.26],0.142546191945313,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,0.45 [0.16-1.31],0.14402296234072,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,0.8 [0.6-1.08],0.145057704952508,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,0.75 [0.5-1.11],0.149192440238805,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,0.78 [0.55-1.1],0.149634265673554,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,KLK10,Kallikrein-10,Wald ratio,1,0.31 [0.06-1.56],0.156395133806984,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD48,CD48 antigen,Inverse variance weighted,14,0.76 [0.51-1.11],0.157932832840263,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,2.23 [0.71-7.04],0.170722526215115,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.66 [0.8-3.42],0.171021658596219,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.77 [0.53-1.12],0.171992617009183,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.64 [0.33-1.23],0.176386907266433,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,0.89 [0.74-1.06],0.176562376434236,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,POF1B,Protein POF1B,Inverse variance weighted,4,1.45 [0.84-2.5],0.176980888473055,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.13 [0.94-1.36],0.177897346328416,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,0.92 [0.81-1.04],0.179166746442964,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.33 [0.87-2.03],0.181077757454138,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.77 [0.51-1.14],0.186777703561317,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.8 [0.57-1.12],0.189124051931542,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.29 [0.88-1.88],0.189431088797083,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.79 [0.55-1.13],0.192636009364222,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.66 [0.35-1.24],0.193296611517337,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PTN,Pleiotrophin,Inverse variance weighted,3,0.64 [0.33-1.25],0.194227047238417,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,0.74 [0.47-1.17],0.198654600261023,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.39 [0.84-2.3],0.199482777914919,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1.1 [0.95-1.28],0.203447706272965,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LGALS9,Galectin-9,Inverse variance weighted,36,1.1 [0.95-1.27],0.205914290737942,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.24 [0.89-1.73],0.206979964684279,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.79 [0.71-4.54],0.217173395769286,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.09 [0.95-1.25],0.217233455906745,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCN4,CCN family member 4,Inverse variance weighted,29,0.91 [0.78-1.06],0.217966438624026,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.2 [0.9-1.6],0.218281777157467,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.54 [0.2-1.45],0.221819541394243,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GUCA2A,Guanylin,Inverse variance weighted,7,1.29 [0.86-1.94],0.223975761022972,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.55 [0.21-1.44],0.224637424758661,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,0.85 [0.66-1.1],0.224909085272885,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNC,Tenascin,Inverse variance weighted,57,0.94 [0.85-1.04],0.228004161962333,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.92 [0.81-1.05],0.233555284446504,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.05 [0.97-1.14],0.234885587974565,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.6 [0.25-1.4],0.235198200725173,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,0.88 [0.71-1.09],0.236353458218552,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,0.88 [0.72-1.09],0.23725325833714,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,1.29 [0.85-1.95],0.238059770705453,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.91 [0.64-5.73],0.24556465973355,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,0.71 [0.4-1.27],0.247768781270487,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.58 [0.72-3.44],0.252124619314154,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,1.15 [0.91-1.45],0.253238484690431,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1.3 [0.83-2.02],0.254063341002507,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.13 [0.91-1.4],0.259718851028371,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CDH2,Cadherin-2,Inverse variance weighted,21,0.84 [0.62-1.14],0.261135217004351,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CALCA,Calcitonin,Inverse variance weighted,13,1.24 [0.85-1.8],0.266680205760979,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.35 [0.79-2.31],0.267560129369468,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.33 [0.8-2.19],0.267915217528787,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.59 [0.23-1.51],0.271507911923889,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.53 [0.71-3.28],0.27691437313916,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MFGE8,Lactadherin,Inverse variance weighted,15,1.2 [0.86-1.65],0.2802286393462,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.91 [0.76-1.08],0.280404322118198,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.39 [0.77-2.51],0.280676346005084,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.11 [0.92-1.33],0.285878479294861,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.6 [0.67-3.79],0.287904064861752,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.22 [0.84-1.77],0.289622534712145,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.41 [0.74-2.66],0.292383258080715,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,UMOD,Uromodulin,Inverse variance weighted,34,0.88 [0.7-1.12],0.29255887511219,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,RETN,Resistin,Inverse variance weighted,19,0.86 [0.64-1.14],0.293081809210621,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PLXNB2,Plexin-B2,Inverse variance weighted,12,1.28 [0.81-2.03],0.294394885352399,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Wald ratio,1,2.22 [0.5-9.97],0.296899357980652,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.21 [0.85-1.72],0.301976830729417,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TFF3,Trefoil factor 3,Inverse variance weighted,10,0.85 [0.63-1.16],0.302290154858115,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NFASC,Neurofascin,Inverse variance weighted,6,0.73 [0.41-1.32],0.303301698309966,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.79 [0.5-1.24],0.305278753598888,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.35 [0.76-2.4],0.306707680133883,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LMOD1,Leiomodin-1,Inverse variance weighted,6,1.18 [0.86-1.6],0.307298129592718,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.79 [0.5-1.24],0.307396744625501,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.69 [0.61-4.69],0.311248132721541,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.84 [0.6-1.18],0.311396381696531,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.27 [0.79-2.04],0.31657491578352,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.31 [0.77-2.23],0.317535730106402,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PSAP,Prosaposin,Inverse variance weighted,13,1.12 [0.89-1.42],0.320727655555096,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.81 [0.54-1.23],0.321038160161892,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.14 [0.88-1.49],0.322461582599188,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GRN,Progranulin,Inverse variance weighted,46,1.06 [0.94-1.19],0.322861916175138,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.46 [0.68-3.12],0.327215284615121,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.37 [0.73-2.57],0.327294636434274,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.24 [0.8-1.93],0.332165078618979,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,1.16 [0.85-1.58],0.335046380412548,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.27 [0.78-2.05],0.335592444568135,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.74 [0.41-1.36],0.335997624071029,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.79 [0.48-1.29],0.336898378255948,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CHGA,Chromogranin-A,Inverse variance weighted,5,1.27 [0.78-2.08],0.339539324392254,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CHGB,Secretogranin-1,Inverse variance weighted,7,0.82 [0.55-1.23],0.34060295709525,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SLAMF7,SLAM family member 7,Inverse variance weighted,16,1.2 [0.82-1.76],0.344136725381718,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.56 [0.17-1.86],0.345010937208503,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL17C,Interleukin-17C,Inverse variance weighted,5,1.39 [0.7-2.77],0.345288465102408,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,0.78 [0.46-1.32],0.348876924761883,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CDH3,Cadherin-3,Inverse variance weighted,10,1.26 [0.78-2.02],0.350089208843613,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,1.6 [0.59-4.36],0.355373509860327,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,2.15 [0.42-11.17],0.361091526807824,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.18 [0.82-1.69],0.368951969485423,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,1.27 [0.75-2.14],0.369586187981383,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LAMB1,Laminin subunit beta-1,Inverse variance weighted,21,0.88 [0.68-1.16],0.37436730236873,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ITGA5,Integrin alpha-5,Inverse variance weighted,18,0.88 [0.66-1.17],0.377191056703031,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.82 [0.54-1.27],0.3774265426957,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,1.1 [0.89-1.36],0.377623146146935,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,RSPO3,R-spondin-3,Inverse variance weighted,5,0.73 [0.36-1.47],0.380060832013189,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ALCAM,CD166 antigen,Inverse variance weighted,4,0.83 [0.55-1.25],0.382854853613265,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.25 [0.75-2.08],0.387692505575909,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LGALS3,Galectin-3,Inverse variance weighted,15,0.86 [0.61-1.21],0.388666584396453,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,1.14 [0.85-1.52],0.389201674289257,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.87 [0.64-1.19],0.392320303396078,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.91 [0.73-1.13],0.393574444418417,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.22 [0.77-1.93],0.395890902577095,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.65 [0.24-1.77],0.396152398256373,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MUC13,Mucin-13,Inverse variance weighted,3,0.53 [0.12-2.3],0.397194791656161,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MMP3,Stromelysin-1,Inverse variance weighted,4,0.68 [0.28-1.66],0.398920797888608,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ROBO1,Roundabout homolog 1,Inverse variance weighted,18,1.14 [0.84-1.57],0.402249687926328,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,1.2 [0.78-1.86],0.406965997919476,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ELN,Elastin,Inverse variance weighted,10,0.84 [0.56-1.27],0.40755206220189,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.84 [0.54-1.28],0.408527485823371,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,0.82 [0.51-1.32],0.409104116947226,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,0.92 [0.77-1.12],0.412659355884892,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1.22 [0.76-1.96],0.413485230300988,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.03 [0.95-1.12],0.415184003715718,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SEMA7A,Semaphorin-7A,Inverse variance weighted,20,0.9 [0.7-1.16],0.415290526723419,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LMNB2,Lamin-B2,Inverse variance weighted,8,0.83 [0.52-1.31],0.417737369975687,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,5,1.18 [0.79-1.76],0.418271585697331,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,0.81 [0.49-1.35],0.419623108341053,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,THBD,Thrombomodulin,Inverse variance weighted,11,0.91 [0.72-1.15],0.421677198000374,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.71 [0.31-1.63],0.424860166921821,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.18 [0.79-1.76],0.430800209738112,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.68 [0.46-6.18],0.431594233705942,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.29 [0.68-2.43],0.431767668482012,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TCN2,Transcobalamin-2,Inverse variance weighted,24,1.05 [0.93-1.19],0.431892256152063,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.28 [0.69-2.39],0.434486342575961,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PYY,Peptide YY,Inverse variance weighted,16,1.09 [0.88-1.35],0.435615560845808,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LGALS4,Galectin-4,Inverse variance weighted,15,0.92 [0.76-1.13],0.435919942127833,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,1.04 [0.94-1.15],0.438260552376108,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.14 [0.82-1.59],0.439833100097669,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.07 [0.89-1.29],0.440331294468974,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,1.41 [0.59-3.37],0.441237998887859,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PENK,Proenkephalin-A,Inverse variance weighted,15,0.91 [0.71-1.16],0.441366200173942,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,1.05 [0.93-1.19],0.443460930038015,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NECTIN4,Nectin-4,Inverse variance weighted,4,0.74 [0.34-1.61],0.444337998586643,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CFC1,Cryptic protein,Inverse variance weighted,11,1.17 [0.78-1.76],0.445030405397083,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.86 [0.59-1.26],0.445710034175489,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.87 [0.61-1.24],0.446671037573081,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,0.95 [0.83-1.08],0.447671042438959,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.9 [0.68-1.18],0.449014142388041,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.61 [0.17-2.2],0.453462712842258,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,VWC2,Brorin,Inverse variance weighted,12,1.16 [0.78-1.73],0.453766618392587,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SCG2,Secretogranin-2,Inverse variance weighted,2,1.34 [0.62-2.9],0.460017492542737,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.91 [0.72-1.16],0.462274358079576,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,REN,Renin,Inverse variance weighted,8,0.82 [0.47-1.42],0.469845266413921,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.93 [0.76-1.13],0.47098197078053,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CSTB,Cystatin-B,Inverse variance weighted,23,1.05 [0.92-1.2],0.476271274470579,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,0.96 [0.86-1.07],0.477037255720464,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.72 [0.29-1.77],0.478097034134814,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,0.8 [0.43-1.48],0.480861766067824,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IMMT,MICOS complex subunit MIC60,Wald ratio,1,1.46 [0.51-4.19],0.481774135987318,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,5,1.38 [0.56-3.44],0.484598575900142,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PCDH17,Protocadherin-17,Inverse variance weighted,44,0.97 [0.88-1.07],0.496693620953858,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.88 [0.61-1.28],0.506169847524566,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,BSG,Basigin,Inverse variance weighted,6,0.84 [0.49-1.43],0.509625625644403,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.19 [0.71-1.98],0.511551861225517,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1.1 [0.83-1.46],0.514248997136909,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.76 [0.33-1.75],0.518076500691172,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,OSM,Oncostatin-M,Inverse variance weighted,6,0.88 [0.59-1.31],0.525098630933943,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.77 [0.35-1.7],0.525874065226606,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.21 [0.67-2.19],0.526220064420557,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ANG,Angiogenin,Inverse variance weighted,9,0.84 [0.5-1.43],0.526597322656715,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MMP8,Neutrophil collagenase,Inverse variance weighted,10,1.11 [0.8-1.54],0.530870188113711,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.06 [0.88-1.29],0.530953482691682,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.06 [0.89-1.26],0.534481621796597,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,1.02 [0.96-1.08],0.535548839137433,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,0.85 [0.5-1.43],0.536505698317962,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,1.21 [0.66-2.21],0.536817478686261,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.67 [0.18-2.43],0.542263945383572,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,25,0.91 [0.66-1.24],0.546736664775638,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.58 [0.09-3.51],0.550488313401564,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.82 [0.44-1.55],0.550504500202893,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,0.81 [0.41-1.61],0.55055473709425,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.58 [0.35-7.22],0.552853442697047,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.66 [0.16-2.64],0.554874742679169,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.13 [0.76-1.67],0.555356673425519,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.09 [0.82-1.46],0.555500434005519,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TMPRSS11D,Transmembrane protease serine 11D,Wald ratio,1,1.49 [0.38-5.79],0.563918140508798,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.86 [0.52-1.43],0.564965415666693,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,0.74 [0.26-2.09],0.56518568784379,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.95 [0.8-1.13],0.565958504096127,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.03 [0.92-1.15],0.569287147639139,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.23 [0.6-2.56],0.573129497356286,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.34 [0.47-3.86],0.581765875524399,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.96 [0.85-1.1],0.58269247394312,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.71 [0.21-2.39],0.582925939487634,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.93 [0.73-1.19],0.583469804684138,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD276,CD276 antigen,Inverse variance weighted,24,0.94 [0.76-1.17],0.585513065330677,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.69 [0.18-2.65],0.58573474291558,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.16 [0.68-2],0.589174490740634,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LGMN,Legumain,Inverse variance weighted,22,1.1 [0.77-1.58],0.593622952730207,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1.11 [0.76-1.62],0.594606053152774,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CPM,Carboxypeptidase M,Inverse variance weighted,19,1.1 [0.78-1.54],0.59903047864133,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.88 [0.56-1.4],0.599865988584655,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SPP1,Osteopontin,Inverse variance weighted,13,1.11 [0.76-1.61],0.600832463969486,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,0.91 [0.65-1.29],0.603907508913293,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD160,CD160 antigen,Inverse variance weighted,24,1.08 [0.81-1.44],0.604294665944608,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.88 [0.54-1.44],0.61470639904279,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.09 [0.78-1.52],0.615382373828972,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.97 [0.88-1.08],0.61937909716254,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.06 [0.84-1.33],0.62035011706226,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL19,Interleukin-19,Inverse variance weighted,10,0.96 [0.8-1.14],0.620783580035633,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.07 [0.81-1.43],0.623815563763619,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.03 [0.92-1.16],0.625577717834596,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.14 [0.68-1.89],0.626440226087947,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1.06 [0.83-1.36],0.628380139907265,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.22 [0.55-2.7],0.629602113553602,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.96 [0.82-1.13],0.630974352490403,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,0.91 [0.62-1.34],0.631895278916905,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MMP7,Matrilysin,Wald ratio,1,0.87 [0.5-1.53],0.631996800273691,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GPR15L,Protein GPR15L,Inverse variance weighted,13,1.05 [0.87-1.26],0.632006149671821,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.93 [0.67-1.27],0.634707935588564,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.2 [0.56-2.55],0.635040012017117,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.13 [0.68-1.87],0.640110982296872,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.07 [0.8-1.43],0.641326630458903,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.15 [0.64-2.07],0.643271831081841,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SLAMF8,SLAM family member 8,Inverse variance weighted,2,1.48 [0.28-7.7],0.643299897321712,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.8 [0.32-2.04],0.645383793925683,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,1.39 [0.34-5.8],0.648054183855575,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.08 [0.78-1.48],0.649378708157195,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,0.86 [0.44-1.68],0.653537627934139,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.88 [0.5-1.55],0.65704822914524,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.87 [0.47-1.61],0.657054505294961,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.89 [0.52-1.51],0.658770955890469,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PI3,Elafin,Inverse variance weighted,18,0.95 [0.77-1.18],0.658863777596773,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1.11 [0.7-1.74],0.659924836667062,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.83 [0.36-1.92],0.660900258507378,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,1.19 [0.54-2.62],0.661409743688995,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CDH1,Cadherin-1,Inverse variance weighted,16,0.96 [0.79-1.16],0.66971872371358,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1.09 [0.74-1.6],0.671236458322959,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SEPTIN8,Septin-8,Inverse variance weighted,4,1.13 [0.64-1.98],0.675702343351618,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.9 [0.54-1.49],0.681971095021874,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,1.14 [0.62-2.08],0.682860025797462,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1.06 [0.81-1.38],0.690848154158688,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,STC2,Stanniocalcin-2,Inverse variance weighted,10,0.9 [0.52-1.54],0.691026558015638,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,1.07 [0.77-1.48],0.695210271908627,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,0.95 [0.72-1.25],0.697268095160113,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.17 [0.53-2.6],0.697854873525565,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.2 [0.47-3.09],0.698311756733577,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,0.86 [0.41-1.83],0.698823912882446,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1.02 [0.93-1.11],0.702236915496407,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,DCN,Decorin,Inverse variance weighted,2,1.23 [0.42-3.63],0.702763989616645,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SPON2,Spondin-2,Inverse variance weighted,3,1.18 [0.51-2.7],0.703287124136487,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,0.94 [0.68-1.29],0.70355931971728,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,0.89 [0.49-1.63],0.704657984682736,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.84 [0.34-2.07],0.705296150560416,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.11 [0.65-1.91],0.706070541577445,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.16 [0.53-2.52],0.706724305173863,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.96 [0.79-1.18],0.70706643714973,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.08 [0.71-1.64],0.710168760496654,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCN5,CCN family member 5,Inverse variance weighted,12,1.04 [0.84-1.28],0.712074154113669,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.06 [0.77-1.46],0.714415968775697,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,AGRN,Agrin,Inverse variance weighted,14,0.94 [0.69-1.29],0.716044630754143,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,RSPO1,R-spondin-1,Inverse variance weighted,8,0.94 [0.66-1.33],0.720423719255653,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,XG,Glycoprotein Xg,Inverse variance weighted,2,0.83 [0.3-2.32],0.723869384464116,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,RTBDN,Retbindin,Inverse variance weighted,2,1.22 [0.41-3.6],0.72446161842594,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,0.82 [0.26-2.55],0.73334165240654,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.89 [0.47-1.71],0.734783050748735,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.97 [0.84-1.13],0.735267700540951,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.05 [0.78-1.43],0.736019531599904,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.93 [0.6-1.43],0.743415343638855,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.09 [0.66-1.78],0.74387530655306,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,1.06 [0.75-1.49],0.747058728038775,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,1.08 [0.68-1.7],0.747574137581083,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.94 [0.63-1.4],0.751035485957707,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCN3,CCN family member 3,Inverse variance weighted,17,0.97 [0.8-1.17],0.752548536817555,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,0.92 [0.54-1.56],0.752605554482949,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.09 [0.65-1.83],0.753162727293567,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,0.98 [0.86-1.12],0.753938104584896,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.92 [0.56-1.52],0.756791214022672,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.22 [0.34-4.34],0.760469457436957,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NRP1,Neuropilin-1,Inverse variance weighted,14,0.94 [0.64-1.4],0.765092027642876,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.09 [0.61-1.95],0.765446459166762,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PRELP,Prolargin,Inverse variance weighted,5,0.86 [0.32-2.32],0.766922174408346,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.94 [0.6-1.45],0.767243250731248,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.84 [0.28-2.59],0.768032858984059,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.05 [0.77-1.41],0.768252452440219,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FBLN2,Fibulin-2,Inverse variance weighted,6,0.93 [0.58-1.5],0.773083131235639,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1.04 [0.8-1.35],0.774036750169687,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,0.92 [0.54-1.58],0.775473173960678,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.03 [0.83-1.27],0.77622199324578,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,1.11 [0.55-2.22],0.77633528358252,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,DSC2,Desmocollin-2,Inverse variance weighted,16,1.03 [0.85-1.25],0.777102606795637,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.86 [0.31-2.41],0.77813254459334,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NECTIN2,Nectin-2,Inverse variance weighted,3,0.78 [0.13-4.58],0.783407279621827,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SNCG,Gamma-synuclein,Inverse variance weighted,47,1.01 [0.92-1.11],0.785153389729329,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MB,Myoglobin,Inverse variance weighted,9,1.06 [0.71-1.57],0.785705849168062,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.01 [0.92-1.12],0.787084124637402,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.05 [0.74-1.47],0.790509184460371,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.02 [0.87-1.19],0.797704129620258,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SDC1,Syndecan-1,Inverse variance weighted,12,1.06 [0.68-1.66],0.798530791404337,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,EPO,Erythropoietin,Inverse variance weighted,11,1.03 [0.81-1.31],0.800867833952318,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,0.94 [0.59-1.51],0.804374355935933,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.89 [0.36-2.22],0.804381301242471,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.09 [0.55-2.16],0.807243126765362,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,1.13 [0.41-3.14],0.810873197269964,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.04 [0.76-1.41],0.811545377317953,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.03 [0.81-1.32],0.811818472711628,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.98 [0.8-1.19],0.811990323340894,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.99 [0.9-1.09],0.816810405216647,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,0.95 [0.6-1.5],0.818476100460813,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD27,CD27 antigen,Inverse variance weighted,9,1.05 [0.67-1.66],0.822289552590506,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.08 [0.51-2.3],0.836661540767264,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.1 [0.44-2.72],0.840148930056868,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.07 [0.55-2.07],0.841044639734098,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.03 [0.78-1.35],0.842930166478137,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,THBS2,Thrombospondin-2,Inverse variance weighted,15,1.03 [0.78-1.35],0.843168564892802,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,1.06 [0.59-1.9],0.843565252766938,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,0.96 [0.61-1.5],0.845260549634994,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,0.95 [0.58-1.56],0.847338637800273,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,1.06 [0.6-1.88],0.847737989710718,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,AOC3,Membrane primary amine oxidase,Inverse variance weighted,34,1.01 [0.9-1.13],0.855530213295971,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,0.98 [0.75-1.27],0.861872282006874,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.93 [0.42-2.07],0.862759411152224,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.05 [0.62-1.77],0.866327267585744,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.02 [0.78-1.33],0.866536462375636,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,1.02 [0.79-1.33],0.867197825116022,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,1.12 [0.29-4.39],0.868526319606701,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.95 [0.49-1.81],0.871206240109914,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.05 [0.56-1.96],0.87199941077838,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.86 [0.13-5.79],0.877869615666897,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,0.94 [0.41-2.12],0.87810578370455,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,3,1.05 [0.54-2.06],0.878616269789916,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.06 [0.49-2.28],0.88163975788389,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.02 [0.75-1.39],0.891668975489958,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CTSL,Cathepsin L1,Inverse variance weighted,29,1.01 [0.83-1.24],0.893773979021992,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,0.97 [0.63-1.51],0.898473096881,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1.04 [0.51-2.14],0.904762367742705,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD99,CD99 antigen,Inverse variance weighted,4,0.97 [0.59-1.61],0.906025178167088,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.98 [0.75-1.29],0.909119766511435,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.96 [0.51-1.82],0.90927775797311,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CALB1,Calbindin,Inverse variance weighted,9,0.98 [0.63-1.5],0.909689710405422,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.03 [0.63-1.67],0.909907490944237,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.99 [0.91-1.09],0.910508664960903,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.98 [0.71-1.36],0.912284205067298,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.02 [0.67-1.55],0.913700442958581,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,1.01 [0.82-1.25],0.914286976972173,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,1.03 [0.58-1.85],0.914430809132853,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,0.98 [0.7-1.37],0.917339028577261,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.99 [0.74-1.31],0.918501033860897,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.98 [0.59-1.6],0.922692311444395,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.01 [0.86-1.19],0.923526553484036,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,17,1.02 [0.73-1.41],0.923824752496502,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.07 [0.24-4.78],0.928431513268944,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,KLK11,Kallikrein-11,Inverse variance weighted,13,1.01 [0.73-1.42],0.930571625711931,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.98 [0.64-1.51],0.930628158890496,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,0.99 [0.73-1.33],0.932203169987493,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.03 [0.55-1.91],0.933375881794019,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.05 [0.32-3.47],0.934119272348982,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.98 [0.53-1.79],0.935100068157944,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.03 [0.55-1.93],0.937554522831275,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PGA4,Pepsin A-4,Inverse variance weighted,7,1.02 [0.64-1.63],0.9376693859269,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.87 [0.03-27.99],0.939154253700564,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.96 [0.27-3.44],0.946080594841142,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CLEC3B,Tetranectin,Inverse variance weighted,2,0.96 [0.32-2.94],0.948178349198162,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,0.99 [0.73-1.34],0.952247260426589,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,0.98 [0.49-1.97],0.954797787309636,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.98 [0.46-2.07],0.956821630657554,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.02 [0.52-1.98],0.957203161705934,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.02 [0.42-2.5],0.957613492039432,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,XCL1,Lymphotactin,Inverse variance weighted,15,1.01 [0.7-1.45],0.959580404039174,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1.01 [0.79-1.28],0.961567679550783,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GAST,Gastrin,Inverse variance weighted,9,1.01 [0.7-1.45],0.963761680766595,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,SPON1,Spondin-1,Inverse variance weighted,4,1.02 [0.46-2.28],0.964171450360061,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.01 [0.61-1.69],0.966587881103799,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.04 [0.17-6.25],0.967049357430046,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,1 [0.82-1.21],0.96992612369577,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PRSS8,Prostasin,Inverse variance weighted,14,0.99 [0.74-1.33],0.97098977667645,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.99 [0.62-1.6],0.971988902383384,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,0.98 [0.34-2.85],0.97459670268969,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MARCO,Macrophage receptor MARCO,Inverse variance weighted,27,1 [0.79-1.25],0.975915594853482,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CD302,CD302 antigen,Inverse variance weighted,11,1.01 [0.61-1.65],0.978662421271915,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,1 [0.72-1.37],0.984147297869115,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1 [0.74-1.35],0.984180545737504,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1 [0.61-1.66],0.984770989005103,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1 [0.72-1.4],0.988158901182627,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CTSS,Cathepsin S,Inverse variance weighted,7,1 [0.58-1.72],0.989735572687519,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1 [0.68-1.45],0.990234233055885,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,TFF2,Trefoil factor 2,Inverse variance weighted,16,1 [0.78-1.29],0.990659860154572,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CFD,Complement factor D,Wald ratio,1,0.99 [0.28-3.57],0.990726729121798,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PGF,Placenta growth factor,Inverse variance weighted,5,1 [0.61-1.65],0.99307304704966,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,CDH6,Cadherin-6,Inverse variance weighted,5,1 [0.54-1.85],0.996618179668024,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1 [0.59-1.7],0.997074497510718,trans
Chapter IX Diseases of the circulatory system,I9_CARDARR,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,1 [0.83-1.21],0.997712279465747,trans
